Transvascular energy ablation showed a 79% response rate in reducing pancreatic cancer pain without opioids. Patients experienced a mean pain reduction of 4.96 points, equating to a 66% improvement in ...

The personal pain goal is inadequate for assessing outcomes of cancer pain management; goals should include function, medication effects, and safety. Cancer patients need a more comprehensive means of ...

A quantitative study was conducted to facilitate understanding of the usability and validity of 3 pain measurement tools, the FPS, the NRS, and the VAS, in measuring pain intensity in the older head ...

New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage patients with otherwise limited treatment options THE ...

The median morphine-equivalent daily dose declined 5-fold over the study period. New research suggests that cancer patients referred for outpatient palliative care may not be receiving adequate ...